Biological Activities Evaluation of Enantiopure Isoxazolidine Derivatives: In Vitro, In Vivo and In Silico Studies

Applied Biochemistry and Biotechnology
Habib MosbahBoulbaba Selmi

Abstract

A series of enantiopure isoxazolidines (3a-c) were synthesized by 1,3-dipolar cycloaddition between a (-)-menthone-derived nitrone and various terminal alkenes. The screened compounds were evaluated for their antioxidant activity by two in vitro antioxidant assays, including β-carotene/linoleic acid bleaching, and inhibition of lipid peroxidation (thiobarbituric acid reactive species, TBARS). The results revealed that compound 3b (EC50 = 0.55 ± 0.09 mM) was the most potent antioxidant as compared to the standard drug (EC50 = 2.73 ± 0.07 mM) using the TBARS assay. Furthermore, the antimicrobial activity was assessed using disc diffusion and microdilution methods. Among the synthesized compounds, 3c was found to be the most potent antimicrobial agent as compared to the standard drug. Subsequently, the acute toxicity study has also been carried out for the newly synthesized compounds and the experimental studies revealed that all compounds were safe up to 500 mg/kg and no death of animals were recorded. The cytotoxicity of these compounds was assessed by the MTT cell proliferation assay against the continuous human cell lines HeLa and compound 3c (GI50 = 46.2 ± 1.2 μM) appeared to be more active than compound 3a (GI50 = 200 ± 2.8 ...Continue Reading

References

May 26, 1998·Environmental Health Perspectives·E Walum
Jun 25, 2003·Archiv der Pharmazie·Kodagahally R Ravi KumarKanchugarakoppal S Rangappa
Sep 10, 2003·Anti-cancer Drugs·Oskar S Frankfurt, Awtar Krishan
Mar 24, 2004·Journal of Ethnopharmacology·Jaouad El HilalyBadiâa Lyoussi
May 18, 2004·Brain Research·Nádia Aléssio Velloso BelléJoão Batista Teixeira Rocha
Sep 17, 2004·Journal of Computer-aided Molecular Design·Alessandro PedrettiGiulio Vistoli
Dec 27, 2006·Food Microbiology·Varaporn VuddhakulSanan Subhadhirasakul
Sep 15, 2007·Pakistan Journal of Biological Sciences : PJBS·Rizna T DewiSofna D S Banjarnahor
May 22, 2010·Chemical Biology & Drug Design·Belinda LohAriberto Fassati
Jul 21, 2010·Natural Product Research·Mehtab ParveenMohammed Ali
Mar 26, 2013·Journal of Molecular Recognition : JMR·Elizabeth Yuriev, Paul A Ramsland
May 15, 2013·Applied Biochemistry and Biotechnology·Carlos Victor Montefusco-PereiraEmerson Silva Lima
Jan 30, 2014·Journal of Medicinal Chemistry·Richard D TaylorAlastair D G Lawson
Jul 25, 2015·Bioorganic & Medicinal Chemistry·Zaman AshrafNajam-us-Sahar Sadaf Zaidi
Aug 12, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mejdi SnoussiVincenzo De Feo
Dec 17, 2016·Chemical Reviews·Mathéo BerthetJean Martinez
Nov 28, 2017·Applied Biochemistry and Biotechnology·Murugesan DineshSelvaraj Mohana Roopan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.